DC Migration Study for Newly-Diagnosed GBM

Clinical trial NCT02366728 · COMPLETED

Trial details

NCT number: NCT02366728
Sponsor: Mustafa Khasraw, MBChB, MD, FRCP, FRACP
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Astrocytoma, Grade IV Giant Cell Glioblastoma Glioblastoma Multiforme

Start date: 2015-10-12
Primary completion: 2020-10-31
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.